Encircling the regions of the pharmacogenomic landscape that determine drug response.

Fernández-Torras, Adrià; Duran-Frigola, Miquel; Aloy, Patrick

Fernández-Torras, Adrià; Duran-Frigola, Miquel; Aloy, Patrick.

Afiliação

Fernández-Torras A; Joint IRB-BSC-CRG Program in Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain.
Duran-Frigola M; Joint IRB-BSC-CRG Program in Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain. miquel.duran@irbbarcelona.org.
Aloy P; Joint IRB-BSC-CRG Program in Computational Biology, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Catalonia, Spain. patrick.aloy@irbbarcelona.org.

Genome Med ; 11(1): 17, 2019 03 26.

Article em En | MEDLINE | ID: mdl-30914058

Assuntos

Resistencia a Medicamentos Antineoplásicos/genética; Estudo de Associação Genômica Ampla/métodos; Variantes Farmacogenômicos; Algoritmos; Linhagem Celular Tumoral; Redes Reguladoras de Genes; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Resistencia a Medicamentos Antineoplásicos / Estudo de Associação Genômica Ampla / Variantes Farmacogenômicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google